GSK plc - SPONSORED ADR (GSK)

Historical Portfolio Holders from Q1 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q1 2024
295 M
Holdings value Q1 2024
$12.6 B
Value change Q1 2024
+$670 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
861
Number of buys Q1 2024
397
Number of sells Q1 2024
-356
Average buys Q1 2024 %
+0.008%
Average sells Q1 2024 %
-0.004%
CUSIP
37733W204
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 295 M $12.6 B +$670 M $42.87 861
2023 Q4 281 M $10.4 B +$141 M $37.06 857
2023 Q3 284 M $10.3 B +$274 M $36.25 819
2023 Q2 276 M $9.84 B +$172 M $35.64 799
2023 Q1 267 M $9.51 B -$215 M $35.58 775
2022 Q4 276 M $9.69 B +$528 M $35.14 773
2022 Q3 262 M $7.71 B +$7.58 B $29.43 679
2022 Q2 4.21 M $183 M +$182 M $43.53 63
2022 Q1 45.2 K $1.97 M -$166 K $43.56 4
2021 Q4 49 K $2.16 M -$24 K $44.10 5
2021 Q3 3.43 K $131 K +$19.6 K $38.21 4
2021 Q2 2.91 K $116 K -$35.7 K $39.82 4
2021 Q1 3.81 K $136 K -$103 K $35.69 4
2020 Q4 6.68 K $246 K -$29.1 K $36.80 3
2020 Q3 7.47 K $280 K -$18.5 K $37.64 3
2020 Q2 7.97 K $325 K -$17.3 K $40.79 3
2020 Q1 8.39 K $316 K -$7.5 K $37.89 3
2019 Q4 8.59 K $404 K +$47.00 $46.99 3
2019 Q3 6.01 K $257 K +$42.70 $42.68 2
2019 Q2 6.01 K $241 K +$280 $40.02 2
2019 Q1 6 K $251 K -$58.5 K $41.79 2
2018 Q4 7.4 K $283 K -$24 K $38.21 2
2018 Q3 8.03 K $323 K -$357 K $40.17 2
2018 Q2 16.9 K $682 K +$80.60 $40.31 2
2018 Q1 16.9 K $661 K +$10.2 K $39.07 2
2017 Q4 16.7 K $591 K -$47.3 K $35.47 2
2017 Q3 18 K $731 K -$110 K $40.60 2
2017 Q2 20.7 K $893 K $0 $43.12 2
2017 Q1 20.7 K $873 K $0 $42.16 2
2016 Q4 20.7 K $797 K +$182 K $38.51 2
2016 Q3 16 K $689 K +$10.8 K $43.13 2
2016 Q2 15.7 K $681 K -$56.3 K $43.34 2
2016 Q1 17 K $690 K $0 $40.55 2